German chemicals firm Evonik reports 24 percent adjusted EBITDA growth and raises its full-year 2026 guidance.
Evonik Industries posted Q2 non-GAAP EPS of €0.65 on revenue of €3.89 billion, up 11.1 percent year-over-year. Organic sales growth reached 14 percent, while adjusted EBITDA climbed 24 percent to €630 million. The adjusted EBITDA margin improved to 16.2 percent.
The company’s prior-year Q2 revenue stood at €3.50 billion, with adjusted EBITDA at €508 million. The current quarter’s performance reflects stronger demand across key segments and operational efficiencies.
Evonik revised its outlook for 2026, signaling confidence in sustained growth amid favorable market conditions.